M. Zhang, “HBV Integration into Host Superenhancers Might Not Be a Risk Factor for Hepatocellular Carcinoma”, MEDIN, vol. 2, no. 4, pp. 309–317, Jun. 2025, doi: 10.47852/bonviewMEDIN52025080.